Clinical Trials
15
Active:0
Completed:15
Trial Phases
3 Phases
Phase 1:4
Phase 2:5
Phase 3:3
Drug Approvals
19
NMPA:19
Drug Approvals
Benidipine Hydrochloride Tablets
- Product Name
- 可力洛
- Approval Number
- 国药准字HJ20181250
- Approval Date
- Jan 20, 2022
NMPA
Benidipine Hydrochloride Tablets
- Product Name
- 可力洛
- Approval Number
- 国药准字HJ20170112
- Approval Date
- Jan 20, 2022
NMPA
Benidipine Hydrochloride Tablets
- Product Name
- 可力洛
- Approval Number
- 国药准字HJ20170110
- Approval Date
- Jan 20, 2022
NMPA
Benidipine Hydrochloride Tablets
- Product Name
- 可力洛
- Approval Number
- 国药准字HJ20181249
- Approval Date
- Jan 20, 2022
NMPA
Benidipine Hydrochloride Tablets
- Product Name
- 可力洛
- Approval Number
- 国药准字HJ20170109
- Approval Date
- Jan 20, 2022
NMPA
Benidipine Hydrochloride Tablets
- Product Name
- 可力洛
- Approval Number
- 国药准字HJ20170111
- Approval Date
- Jan 20, 2022
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (35.7%)Phase 1
4 (28.6%)Phase 3
3 (21.4%)phase_2_3
2 (14.3%)No trials found
News
No news found